Corinaldesi R, Stanghellini V, Raiti C, Rea E, Salgemini R, Barbara L
Gut. 1987 Mar;28(3):300-5. doi: 10.1136/gut.28.3.300.
In a double blind crossover comparison with placebo, the effects of cisapride (10 mg tid for two weeks), a non-antidopaminergic gastrointestinal prokinetic drug, on gastric emptying times and on symptoms were evaluated in 12 patients with chronic idiopathic dyspepsia and gastroparesis. Gastric emptying was studied by a radioisotopic gamma camera technique. The test meal was labelled in the solid component (99mTc-sulphur colloid infiltrated chicken liver). Nine symptoms (nausea, belching, regurgitations, vomiting, postprandial drowsiness, early satiety, epigastric pain or burning, heartburn) were graded weekly on a questionnaire. Cisapride was significantly more effective than placebo in shortening the t1/2 of gastric emptying (p2 = 0.04), but no significant difference was observed between the two treatments with regard to the improvement of total symptom score (p2 = 0.09). No side effects were reported during the study.
在一项与安慰剂的双盲交叉比较中,对12例慢性特发性消化不良和胃轻瘫患者评估了西沙必利(10毫克,每日三次,共两周)(一种非抗多巴胺能胃肠促动力药物)对胃排空时间和症状的影响。通过放射性同位素γ相机技术研究胃排空。测试餐在固体成分中标记(99mTc-硫胶体浸润鸡肝)。每周通过问卷对九种症状(恶心、嗳气、反流、呕吐、餐后嗜睡、早饱、上腹部疼痛或烧灼感、烧心)进行评分。西沙必利在缩短胃排空t1/2方面比安慰剂显著更有效(p2 = 0.04),但在改善总症状评分方面,两种治疗之间未观察到显著差异(p2 = 0.09)。研究期间未报告副作用。